HDAC9 and acute myeloid leukemia: Fiskus and team found that co-treatment of BRD4 antagonist (JQ1) and HDAC inhibitor panobinostat showed promising results against human acute myeloid leukemia (AML) and the co-treatment was more effective in the induction of apoptosis than individual treatment with either of the inhibitors [65].